We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The White House has asked Congress for $2.5 billion in emergency funding to support the government’s response to the coronavirus outbreak — including more than a billion dollars for vaccine development — as a senior CDC official predicted a “community spread” of the virus in the U.S. Read More
A blockchain-based drug tracking network is capable of meeting future supply chain regulatory requirements, according to pharma companies that took part in a pilot program run by the FDA. Read More
The FDA released a new version of its Purple Book for biological product developers in a searchable database that links each biosimilar and interchangeable with its reference product. Read More
The FDA hit a South Korean drug manufacturer for serious violations at its Chuncheon, Gangwon facility, including lax investigations and testing deficiencies. Read More
The World Health Organization (WHO) has launched a pilot program aimed at increasing insulin access by prequalifying biotherapeutic products that contain human insulin as an active ingredient. Read More
Washington, Wisconsin and Minnesota advanced new efforts last week aimed at lowering prescription drug prices, joining more than 128 drug pricing bills making their way through legislatures across the country. Read More
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) wrote up a drug manufacturer in Bangalore, India for data integrity and other serious violations observed during a December 13 inspection. Read More